ScienceMedia, Inc.

ScienceMedia, Inc. is dedicated to providing innovative clinical training solutions tailored for the life sciences sector, enhancing competency and safety in clinical trials and medical practices. Founded in 1995 in San Diego, US, ScienceMedia, Inc. focuses on delivering specialized training solutions for the life sciences industry.

The company was established by Michelle Youngers, with Mark Surles currently serving as CEO. ScienceMedia has completed one deal, receiving Series B funding in February 2020. ScienceMedia specializes in providing scientifically validated clinical training solutions specifically designed for the life sciences industry. Their core offerings include products such as SMi Source, SMi Trial, and SMi Engage, which are geared towards enhancing clinical competency among life sciences professionals, trial participants, and various stakeholders involved in clinical development.

These platforms facilitate effective training through innovative educational tools that aim to prevent protocol deviations, ensure patient safety, and optimize study outcomes. ScienceMedia's clientele comprises pharmaceutical companies, biopharmaceutical organizations, and healthcare institutions, with a focus on global markets including North America, Europe, and select regions in Asia. Their products serve a diverse user base, which includes clinical development teams, medical affairs departments, and commercial partners looking to improve their clinical training methodologies. ScienceMedia generates revenue primarily through subscription-based models and partnerships with life sciences organizations.

Clients typically engage in contracts for access to ScienceMedia's suite of training solutions, with agreements structured around annual or multi-year subscriptions, allowing organizations to tailor their usage based on specific training needs. The transaction structure caters predominantly to business-to-business (B2B) interactions, with services often packaged in comprehensive training solutions that may include customized content development and ongoing support. While specific pricing details for individual products are not disclosed, the company’s offerings are designed to provide value through enhanced clinical training efficiency and educational outcomes, thereby justifying the investment from its clients in the life sciences sector. In the near future, ScienceMedia plans to launch additional products aimed at further enhancing clinical training efficiency, with specific release dates yet to be announced.

The company is targeting expansion into new markets, focusing on regions in Asia to coincide with its growth strategy. The Series B funding raised in February 2020 will be utilized to support these initiatives, facilitating the development of new training solutions and reinforcing its market presence.